Arovella Therapeutics Expands Share Issuance Strategy
PremiumCompany AnnouncementsArovella Therapeutics Expands Share Issuance Strategy
26d ago
Arovella Therapeutics Issues New Shares Amid Cancer Therapy Development
Premium
Company Announcements
Arovella Therapeutics Issues New Shares Amid Cancer Therapy Development
28d ago
Arovella Therapeutics Advances iNKT Cell Therapy Platform
Premium
Company Announcements
Arovella Therapeutics Advances iNKT Cell Therapy Platform
28d ago
Arovella Therapeutics Seeks ASX Share Quotation
PremiumCompany AnnouncementsArovella Therapeutics Seeks ASX Share Quotation
2M ago
Arovella Therapeutics Unveils iNKT Therapy Advancements
Premium
Company Announcements
Arovella Therapeutics Unveils iNKT Therapy Advancements
2M ago
Arovella Therapeutics Webinar on iNKT Cell Therapy
Premium
Company Announcements
Arovella Therapeutics Webinar on iNKT Cell Therapy
2M ago
Arovella Therapeutics Affirms Strong Governance
PremiumCompany AnnouncementsArovella Therapeutics Affirms Strong Governance
3M ago
Arovella Therapeutics Posts Lower Annual Loss
Premium
Company Announcements
Arovella Therapeutics Posts Lower Annual Loss
3M ago
Arovella’s ALA-101 Gains FDA Nod Towards Trials
Premium
Company Announcements
Arovella’s ALA-101 Gains FDA Nod Towards Trials
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100